Other key analyst calls under $10 were as follows:
Agile Therapeutics Inc. (NASDAQ: AGRX) was named in the Janney Capital Markets report of top small-cap ideas after the market sell-off in a note sent out on Thursday. The firm indicated that it has a Buy rating and a fair value of $18, quite a bit higher than the $6.40 share price in the report and the $6.00 price after the stock slid even more. One key driver is an unmet need for a patch contraceptive option.
Aratana Therapeutics Inc. (NASDAQ: PETX) was started as Overweight with a $17 price target at Piper Jaffray on Tuesday. What was interesting here is that this was above $10 late on Friday ($10.45), but it had traded under $10 each day this past week, so it still qualifies under the $10 barrier.
BioAmber Inc. (NYSE: BIOA) was started as Buy with a $16 price target at Canaccord Genuity on Wednesday. This is almost a call to double from the $8.21 prior closing price, based on it building a renewable chemicals business. Shares were at $8.74 late on Friday, against a 52-week range of $6.00 to $15.29.
Calix Inc. (NYSE: CALX) was raised to Buy from Neutral with a $12 price target at Goldman Sachs on Wednesday. The prior close was $8.88, and this stock had popped as high as about $9.25 before retreating to around $8.65 late on Friday. What stands out here is that Goldman Sachs rarely makes calls on $440 million market cap stocks. Calix is into broadband communications access systems and software for fiber and copper-based network architectures, and its stock has a 52-week range of $7.12 to $13.36.
Novavax Inc. (NASDAQ: NVAX) was started as Overweight with a price target of $7 at J.P. Morgan on Tuesday. Shares were trading at $4.48 on Friday, indicating upside of some 56%. This speculative biotech has a market cap of just over $1 billion, and the 52-week range is $2.68 to $6.95.
Pacific Coast Oil Trust (NYSE: ROYT) was raised to Buy from Hold at Stifel on Thursday. The stock was trading at $9.45 late on Friday. What is interesting here is that just a month earlier this trust was downgraded by Stifel, and a month earlier that it was upgraded. The $10 price target doesn’t sound like much upside here, but you have to consider its 11%-plus dividend.
Unilife Corp. (NASDAQ: UNIS) rose for the second time last week on Wednesday, after a report from a firm called Griffin Securities drove shares up with a massive upside call around $13.50. We are adding no color due to the this likely being an all-or-none call.
Vocera Communications Inc. (NYSE: VCRA) was raised to Outperform from Market Perform with a $10 price target at FBR Capital Markets on Wednesday. This was on the heels of a $7.64 close, and this stock was up at $8.62 on Friday. Also be advised that this stock’s 52-week range is $7.58 to $19.33.